TRUMP MARKET MOVES: Will These Be Next U.S. Equity Stakes?Hims stock surged Wednesday, nearing a buy point, after the telehealth behemoth announced a menopause care program.The move is largely expected after Hims & Hers Health (HIMS) announced a testosterone replacement launch last month, Leerink Partners analyst Michael Cherny said in a report."It is a logical extension of both the Hers brand and the recent (hormone replacement therapy) market entry," he said. "We expect the push into menopause to help the ...